The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sunitinib to upregulate IFNg-STAT1 signaling and to increase indoleamine 2,3-dioxygenase (IDO) expression in renal cell carcinoma (RCC).
 
Eric Jonasch
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Exelixis; GlaxoSmithKline; Novartis; Onyx; Pfizer
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Pfizer
 
Anh Hoang
No Relationships to Disclose
 
Mianen Sun
No Relationships to Disclose
 
Lijun Zhou
No Relationships to Disclose
 
Zhiyong Ding
No Relationships to Disclose
 
Xuesong Zhang
No Relationships to Disclose
 
Shanshan Bai
No Relationships to Disclose
 
Nizar M. Tannir
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Pfizer
Travel, Accommodations, Expenses - Exelixis; GlaxoSmithKline; Novartis; Pfizer
 
Xiande Liu
No Relationships to Disclose